KeViRX
About:
KeViRx is a biotechnology company that develops therapeutics for cancer and respiratory disorders.
Website: https://kevirx.com
Twitter/X: kevirx1
Top Investors: Activation Capital, U.S. Department of Defense
Description:
Total Funding Amount:
$1.99M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Charlottesville, Virginia, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)kevirx.com
Founders:
Elizabeth Sharlow, John Lazo, Peter Wipf
Number of Employees:
1-10
Last Funding Date:
2024-10-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai